Show
Sort by
-
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc) : a multicentre, phase 2-3, randomised, controlled trial
-
Soft tissue angiofibroma : clinicopathologic, immunohistochemical and molecular analysis of 14 cases
-
The CpG island methylator phenotype: what's in a name?
-
- Journal Article
- A1
- open access
NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma